Biomaterial-based delivery platforms for transdermal immunotherapy.
Dahri M, Beheshtizadeh N, Seyedpour N, Nakhostin-Ansari A, Aghajani F, Seyedpour S, Masjedi M, Farjadian F, Maleki R, Adibkia K.
Dahri M, et al.
Biomed Pharmacother. 2023 Sep;165:115048. doi: 10.1016/j.biopha.2023.115048. Epub 2023 Jun 28.
Biomed Pharmacother. 2023.
PMID: 37385212
Free article.
Review.
In addition, transdermal immunotherapy using vaccines has been reviewed for Ebola, Neisseria gonorrhoeae, Hepatitis B virus, Influenza virus, respiratory syncytial virus, Hand-foot-and-mouth disease, and Tetanus....
In addition, transdermal immunotherapy using vaccines has been reviewed for Ebola, Neisseria gonorrhoeae, Hepatitis B virus, Influenz …